The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Lamisil 1% w/w Cream



Karo Pharma ABPA22650/009/001

Main Information

Trade NameLamisil 1% w/w Cream
Active SubstancesTerbinafine hydrochloride
Dosage FormCream
Licence HolderKaro Pharma AB
Licence NumberPA22650/009/001

Group Information

ATC CodeD01AE Other antifungals for topical use
D01AE15 terbinafine

Status

License statusAuthorised
Licence Issued12/07/1993
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back